SCOPUS 정보 검색 플랫폼

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 7, 2006, Pages

Modulation of Toll-like receptor expression: A further effect of statins? [2]

(2) Alves Filho, José C a Cunha, Fernando Q a

a UNIVERSITY OF SÃO PAULO (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CERIVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, HUMAN;

CARDIOVASCULAR DISEASE; CORRELATION ANALYSIS; DOSE RESPONSE; ENDOTOXEMIA; HUMAN; IMMUNOMODULATION; LETTER; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SIGNAL TRANSDUCTION; BLOOD; DRUG ANTAGONISM; METABOLISM; MONOCYTE; NOTE;

HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MONOCYTES; TOLL-LIKE RECEPTOR 4;

EID: 33745935660 PISSN: 10795642 EISSN: None Source Type: Journal
DOI: 10.1161/01.ATV.0000223146.16466.af Document Type: Letter

Times cited : (3)

References (7)

1
- 0033984436
- Current perspectives on statins
- Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation. 2000;101:207-213.
- (2000) Circulation , vol.101 , pp. 207-213
- Maron, D.J.¹ Fazio, S.² Linton, M.F.³

2
- 21544452747
- Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes
- Methe H, Kim JO, Kofler S, Nabauer M, Weis M. Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes. Arterioscler Thromb Vasc Biol. 2005;25:1439-1445.
- (2005) Arterioscler Thromb Vasc Biol , vol.25 , pp. 1439-1445
- Methe, H.¹ Kim, J.O.² Kofler, S.³ Nabauer, M.⁴ Weis, M.⁵

3
- 33750360916
- Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo
- In press
- Niessner A, Steiner S, Speidl WS, Pleiner J, Seidinger D, Maurer G, Goronzy JJ, Weyand CM, Kopp CW, Huber K, Wolzt M, Wojta J. Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis. In press.
- Atherosclerosis
- Niessner, A.¹ Steiner, S.² Speidl, W.S.³ Pleiner, J.⁴ Seidinger, D.⁵ Maurer, G.⁶ Goronzy, J.J.⁷ Weyand, C.M.⁸ Kopp, C.W.⁹ Huber, K.¹⁰ Wolzt, M.¹¹ Wojta, J.¹²

4
- 0038047587
- Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality
- Williams DL, Ha T, Li C, Kalbfleisch JH, Schweitzer J, Vogt W, Browder IW. Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit Care Med. 2003; 31:1808-1818.
- (2003) Crit Care Med , vol.31 , pp. 1808-1818
- Williams, D.L.¹ Ha, T.² Li, C.³ Kalbfleisch, J.H.⁴ Schweitzer, J.⁵ Vogt, W.⁶ Browder, I.W.⁷

5
- 31344481400
- Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis
- Alves-Filho JC, de Freitas A, Russo M, Cunha FQ. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit Care Med. 2006;34:461-470.
- (2006) Crit Care Med , vol.34 , pp. 461-470
- Alves-Filho, J.C.¹ De Freitas, A.² Russo, M.³ Cunha, F.Q.⁴

6
- 2642553075
- HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis
- Merx MW, Liehn EA, Janssens U, Lutticken R, Schrader J, Hanrath P, Weber C. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation. 2004;109:2560-2565.
- (2004) Circulation , vol.109 , pp. 2560-2565
- Merx, M.W.¹ Liehn, E.A.² Janssens, U.³ Lutticken, R.⁴ Schrader, J.⁵ Hanrath, P.⁶ Weber, C.⁷

7
- 0033842917
- Cerivastatin improves survival of mice with LPS-induced sepsis
- Ando H, Takamura T, Ota T, Nagai Y, Kobayashi K. Cerivastatin improves survival of mice with LPS-induced sepsis. J Pharmacol Exp Ther. 2000;294:1043-1046.
- (2000) J Pharmacol Exp Ther , vol.294 , pp. 1043-1046
- Ando, H.¹ Takamura, T.² Ota, T.³ Nagai, Y.⁴ Kobayashi, K.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.